"Even in this time of uncertainty, Mayo Clinic is a place for hope and healing — and we're delivering the care you need. Mayo Clinic follows carefully designed, rigorously enforced safety precautions for anyone who needs face-to-face care. We're safely treating all patients, both in person and through virtual visits, in adherence with federal and state executive orders and guidance. Mayo Clinic provides expert care to everyone who needs healing. That means combining our comprehensive, integrated care with a seamless patient experience to provide exactly the care you need. Mayo Clinic Hospital in Arizona is a seven-story facility with 268 licensed beds, 21 operating rooms and an emergency department."

During the past decade, Mayo Clinic Hospital conducted 158 clinical trials. In the 10-year time frame, 158 clinical trials started and 64 clinical trials were completed, i.e. on average, 40.5% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 39 clinical trials were completed. i.e. 92.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mayo Clinic Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 64 trials, followed by "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "Mayo Clinic" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "Pfizer" with 8 trials sponsored. Other sponsors include 125 different institutions and companies that sponsored additional 95 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mayo Clinic Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 44 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Thoratec Corporation" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator and "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include 63 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "Mayo Clinic Hospital" are "Metastatic Malignant Solid Neoplasm" (7 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Recurrent Fallopian Tube Carcinoma" (5 trials), "Recurrent Primary Peritoneal Carcinoma" (5 trials) and "Stage IV Lung Cancer AJCC v8" (5 trials). Many other conditions were trialed in "Mayo Clinic Hospital" in a lesser frequency.

Most popular intervention types in "Mayo Clinic Hospital" are "Drug" (169 trials), "Other" (76 trials), "Biological" (62 trials), "Procedure" (51 trials) and "Radiation" (26 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (25 trials), "Biospecimen Collection" (24 trials), "Laboratory Biomarker Analysis" (23 trials), "Placebo" (23 trials) and "Quality-of-Life Assessment" (22 trials). Other intervention names were less common.

The vast majority of trials in "Mayo Clinic Hospital" are 209 trials for "All" genders, 17 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Mayo Clinic Hospital". undefined are not yet recruiting, 59 are recruiting, 72 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 58 completed trials in Mayo Clinic Hospital, 6 suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Mayo Clinic Hospital, 44 "Phase 1" clinical trials were conducted, 102 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 19 trials that are defined as “Not Applicable".